Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)
NCT00725686
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Age-Related Macular Degeneration
Interventions
DRUG:
PF-04523655
Sponsor
Quark Pharmaceuticals
Collaborators
[object Object]